Premium
Delivery of comprehensive cancer care at Kaiser Permanente
Author(s) -
Glass Andrew
Publication year - 1998
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/(sici)1097-0142(19980515)82:10+<2076::aid-cncr17>3.0.co;2-8
Subject(s) - medicine , capitation , family medicine , health care , cancer , medline , managed care , nursing , economics , economic growth , political science , law
BACKGROUND Kaiser Permanente (KP) is a large health maintenance organization (HMO) operating in 14 states and caring for 8,000,000 members in hundreds of facilities staffed by thousands of physicians and support personnel. Cancer care is provided to these KP members as part of the health care package. METHODS KP insures members for all their health care needs and provides needed services in their own facilities except in rare circumstances. Professional services are provided by physicians of the Permanente Medical Groups, locally governed groups of physicians contractually bound to Kaiser Permanente by capitation agreements. These agreements cover the full range of services for cancer and all other diseases. KP uses evidence‐based guidelines to rationalize the provision and delivery of medical care for its members. A large investment in technology has allowed these guidelines to be generally available on local intranets and has facilitated the development of a computerized medical record and linkages to multiple clinical and administrative databases for all providers. Several of the KP regions have strong commitments to research in the public domain and have integrated this effort into the clinical practice of oncology, particularly in clinical trials in cancer treatment and prevention. Research efforts also exist in the areas of cancer epidemiology and outcomes. RESULTS Cancer care is integrated fully into the comprehensive medical care provided the KP member. Health benefits cover the full range of cancer prevention and treatment without distinction by diagnosis. CONCLUSIONS Within the broad range of health care options in the U.S., KP represents a good example of the value of a large HMO to deliver comprehensive general medical and oncologic care. Cancer 1998;82:2076‐80. ©; 1998 American Cancer Society.